Improve walking with mixed reality
- Trial ID
- NCT06459154
- Official Title
- The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease. Randomized Control Trial
- Goal
- Improve walking with mixed reality
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Nicosia
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease
- Interventions
- Mixed Reality, Traditional Physiotherapy
Summary For Families
The goal is to see whether using mixed reality exercises can boost quality of life for people with Parkinson's, especially by improving gait, balance, and everyday movement compared with standard physiotherapy. Mixed reality overlays virtual cues on the real world to guide movements, give real-time visual and audio feedback, and make walking and balance exercises more engaging and repetitive, while the comparison arm receives traditional physiotherapy. They're looking for people who can walk independently, have normal thinking ability, and are Greek native speakers, and they exclude those with other neurological disease, uncontrolled heart problems, recent musculoskeletal surgery, use of a walking aid, or significant vision loss; one phase accepts adults 18 and older and a later phase focuses on ages 60 and up. The trial is small, about 15 participants, run by the University of Nicosia.
Locations
- University of Nicosia, Nicosia, Engomi, Cyprus
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mixed Reality. The goal is to see whether using mixed reality exercises can boost quality of life for people with Parkinson's, especially by improving gait, balance, and everyday movement compared with standard physiotherapy. Mixed reality overlays virtual cues on the real world to guide movements, give real-time visual and audio feedback, and make walking and balance exercises more engaging and repetitive, while the comparison arm receives traditional physiotherapy. They're looking for people who can walk independently, have normal thinking ability, and are Greek native speakers, and they exclude those with other neurological disease, uncontrolled heart problems, recent musculoskeletal surgery, use of a walking aid, or significant vision loss; one phase accepts adults 18 and older and a later phase focuses on ages 60 and up. The trial is small, about 15 participants, run by the University of Nicosia.
- Who can participate?
- Participants must be between 60 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.